Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA<sup>2</sup> LEN study.

Publication Year: 2020

DOI:
10.1111/cea.13759

PMCID:
PMC7983924

PMID:
33053244

Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"None of the authors report any conflict of interests."

Evidence found in paper:

"Funding information EU FP6 project GA2LEN (EU contract nr FOOD‐CT‐2004‐506378), the Swedish Asthma and Allergy Association's Research Foundation, the Swedish Heart Lung Foundation, the ChAMP (the Centre for Allergy Research Highlights Asthma Markers of Phenotype) consortium which is funded by the Karolinska Institutet, AstraZeneca & Science for Life Laboratory Joint Research Collaboration. Data cannot be made freely available as they are subject to secrecy in accordance with the Swedish Public Access to Information and Secrecy Act, but can be made available to researchers upon request (subject to a review of secrecy)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025